Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep - they stop ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

(Ivanhoe Newswire) - Obstructive sleep apnea or OSA affects nearly a billion ... there may be another option for Roger — a drug called tirzepatide, also known as Mounjaro or Zepbound.

Opens in a new tab or window The FDA recently approved the first drug specifically for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity: tirzepatide (Zepbound).

Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...

Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...

He also has mild, untreated sleep apnea. He would like to try one of ... decreased alcohol use during treatment with semaglutide or tirzepatide. These results have not been confirmed with a ...